BAT denies smoking claims
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.BAT Industries, the beleaguered tobacco and financial services group, yesterday launched a searing attack on a magazine article that claimed to have finally demonstrated a direct causal link between smoking and lung cancer. Martin Broughton, chief executive, told City analysts and journalists "we have not concealed, we do not conceal and we will never conceal" in a last-ditch attempt to put a floor under BAT's tumbling share price.
He said: "We have no internal research which proves that smoking causes lung cancer or other diseases or, indeed, that smoking is addictive."
He said BAT supported independent research, with no restrictions on the publication of its results, and he warned that "there is still a lack of understanding of the mechanisms of diseases attributed to smoking".
Mr Broughton said: "We recognise that smoking has become a controversial subject, but I wish to stress that we are a responsible company and there is plenty of evidence to support that claim."
Analysts were surprised that Mr Broughton had gone so far in his claims about the lack of link between cigarettes and disease. They were especially surprised that he should deny that smoking cigarettes was addictive.
BAT's most vigorous defence to date of its position follows an escalation this year of the anti-smoking lobby's attacks on the tobacco giants. The company's US subsidiary, Brown & Williamson, is appealing against a $750,000 compensation order in favour of the widow of a Florida smoker, a judgement which has encouraged many other individuals to file cases against tobacco companies.
That, together with the prospect of the re-election of fervent anti-smoker Bill Clinton, has caused a slump in the value of BAT's shares since they peaked in January at 579p. After a further 7p fall yesterday, they closed at 429p, at which level the value of the group has fallen from almost pounds 18bn to just over pounds 13bn. The fall yesterday came despite a 9 per cent rise in group pre-tax profits for the nine months to September from pounds 1.87bn to pounds 2.04bn.
Investment column, page 22
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments